,
your personalized virtual assistant to find clinical trials. Go head, 
Peter Engel, MD
The Lindner Center for Research ...Cincinnati, Ohio - 45219 The Lindner Research CenterCincinnati, Ohio - 45219 (513-585-1777) Lindner CenterCincinnati, Ohio - 45219 (513-585-1777) University of CincinnatiCincinnati, Ohio - 45267 (513-558-4444) Lindner Clinical Trials CenterCincinnati, Ohio - 45219 (513-585-1777) The Lindner Clinical Trial CenterCincinnati, Ohio - 45219 |
- CLINICAL TRIALS 6
- CONDITIONS5
- INTERVENTIONS6
- SINCE2006
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
July 2009 - February 2012
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
May 2006 - December 2010
A 16-Week International Multicenter Double-Blind Randomized Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension (FREEDOM-C2)
June 2009 -
Double Blind Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
April 2008 - December 2011
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
April 2006 - June 2012
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
January 2009 - December 2015
Hypertension
Hypertension, Pulmonary
Fibrosis
Sarcoidosis
Pulmonary Fibrosis
Placebo
Ambrisentan Or Placebo
Oral Treprostinil (Ut-15c) Sustained Release Tablets
Bosentan
Ut-15c
Cicletanine Hc1 Or Placebo
